|Articles|March 23, 2023
High-Speed Sensitive Analysis of Sunitinib and Related Metabolites Through UPLC-MS/MS
Author(s)Waters
Tyrosine Kinase Inhibitors (TKIs) are a class of small molecule drugs used to alter cell growth pathways for the treatment of cancer. Specifically, Sunitinib, a TKI on the market, is available to treat a variety of cancers including pancreatic cancer. Here we create a method to support the therapeutic drug monitoring of Sunitinib and its active metabolite.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
High-throughput Headspace Analysis of Volatile Nitrosamines and their Secondary Amine Precursors
2
GC-IMS Profiling of Flavor and Quality Changes in Cooked Crayfish
3
Detecting Estrogen Signatures in MCN Tumors via Targeted LC-MS/MS
4
Best of the Week: The Scientific Method in the Age of AI, Rewiring the Fundamentals
5
